MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM NEW
Total 13F shares
6,191,196
Share change
+499,588
Total reported value
$37,962,036
Put/Call ratio
127%
Price per share
$6.13
Number of holders
54
Value change
+$2,341,497
Number of buys
39
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q2 2015

As of 30 Jun 2015, MEDGENICS INC - COM NEW (MDGN) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,191,196 shares. The largest 10 holders included Broadfin Capital, LLC, Opaleye Management Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 54 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.